Price
$12.06
Decreased by -1.15%
Dollar Volume
9.06 M
ADR%
5.56
Earnings Report Date (estimate)
Jan 4, 23 (-0.01)
Market Cap.
471.64 M
Shares Float
76.33 M
Shares Outstanding
39.11 M
Beta
0.73
Price / Earnings
-11.79
BPR
5.70
20D Range
11.93 14.97
50D Range
11.93 21.88
200D Range
11.93 24.87
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Oct 6, 22 -0.06
Decreased by -400.00%
-0.02
Decreased by -200.00%
Apr 7, 22 0.03
Increased by +200.00%
-0.01
Increased by +400.00%
Jan 6, 22 -0.02
Decreased by -200.00%
0.01
Decreased by -300.00%
Sep 30, 21 -0.02
Increased by +66.67%
-0.04
Increased by +50.00%
Mar 30, 21 0.02
Increased by +100.00%
-0.02
Increased by +200.00%
Jan 7, 21 0.01
Decreased by -83.33%
-0.02
Increased by +150.00%
Sep 29, 20 0.02
Decreased by -75.00%
-0.07
Increased by +128.57%
Jul 16, 20 -0.06
Decreased by -124.00%
-0.06
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Aug 31, 22 81.54 M
Increased by +5.93%
-13.00 M
Decreased by -86.52%
Decreased by -15.95%
Decreased by -76.07%
May 31, 22 87.00 M
Increased by +13.22%
-6.27 M
Increased by +67.81%
Decreased by -7.20%
Increased by +71.57%
Feb 28, 22 73.97 M
Increased by +3.92%
-4.96 M
Decreased by -39.90%
Decreased by -6.70%
Decreased by -34.63%
Nov 30, 21 78.28 M
Increased by +7.57%
-8.35 M
Decreased by -95.67%
Decreased by -10.67%
Decreased by -81.89%
Aug 31, 21 76.97 M
Increased by +9.62%
-6.97 M
Decreased by -63.36%
Decreased by -9.06%
Decreased by -49.02%
May 31, 21 76.84 M
Increased by +31.73%
-19.47 M
Increased by +87.61%
Decreased by -25.34%
Increased by +90.59%
Feb 28, 21 71.18 M
Increased by +2.01%
-3.54 M
Increased by +37.92%
Decreased by -4.98%
Increased by +39.15%
Nov 30, 20 72.77 M
Increased by +3.95%
-4.27 M
Decreased by -55.99%
Decreased by -5.87%
Decreased by -50.06%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.